Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil Musilek

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Mini Reviews in Medicinal Chemistry|March 7, 2006
Structural requirements of acetylcholinesterase reactivatorsKamil Kuca, Daniel Juna, Kamil Musilek
Protein and Peptide Letters|June 11, 2009
Evaluation of aflatoxin B1--acetylcholinesterase dissociation kinetic using the amperometric biosensor technology: prospect for toxicity mechanismMiroslav Pohanka, Kamil Musilek, Kamil Kuca
Current Medicinal Chemistry|May 16, 2009
Progress of biosensors based on cholinesterase inhibitionMiroslav Pohanka, Kamil Musilek, Kamil Kuca
Current Computer-Aided Drug Design|June 25, 2013
In silico pharmacophore modeling on known pyridinium oxime reactivators of cyclosarin (GF) inhibited AChE to Aid discovery of potential, more efficacious novel non-oxime reactivatorsApurba K Bhattacharjee, Kamil Musilek, Kamil Kuca
Toxicology|December 7, 2007
An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and miceJiri Kassa, Jana Karasova, Kamil Musilek, et al.
Mini Reviews in Medicinal Chemistry|October 16, 2008
The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabunJiri Kassa, Kamil Kuca, Jana Karasova, et al.
International Journal of Molecular Sciences|June 16, 2011
In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesteraseDaniel Jun, Lucie Musilova, Kamil Musilek, et al.
Basic & Clinical Pharmacology & Toxicology|October 11, 2011
A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned miceJiri Kassa, Kamil Musilek, Marketa Koomlova, et al.
Neurotoxicity Research|April 24, 2007
In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 4, 2020
Taking advantage of cellular uptake of ferritin nanocages for targeted drug deliveryBarbora Tesarova, Kamil Musilek, Simona Rex, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Mini Reviews in Medicinal Chemistry|March 7, 2006
Structural requirements of acetylcholinesterase reactivatorsKamil Kuca, Daniel Juna, Kamil Musilek
Protein and Peptide Letters|June 11, 2009
Evaluation of aflatoxin B1--acetylcholinesterase dissociation kinetic using the amperometric biosensor technology: prospect for toxicity mechanismMiroslav Pohanka, Kamil Musilek, Kamil Kuca
Current Medicinal Chemistry|May 16, 2009
Progress of biosensors based on cholinesterase inhibitionMiroslav Pohanka, Kamil Musilek, Kamil Kuca
Current Computer-Aided Drug Design|June 25, 2013
In silico pharmacophore modeling on known pyridinium oxime reactivators of cyclosarin (GF) inhibited AChE to Aid discovery of potential, more efficacious novel non-oxime reactivatorsApurba K Bhattacharjee, Kamil Musilek, Kamil Kuca
Toxicology|December 7, 2007
An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and miceJiri Kassa, Jana Karasova, Kamil Musilek, et al.
Mini Reviews in Medicinal Chemistry|October 16, 2008
The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabunJiri Kassa, Kamil Kuca, Jana Karasova, et al.
International Journal of Molecular Sciences|June 16, 2011
In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesteraseDaniel Jun, Lucie Musilova, Kamil Musilek, et al.
Basic & Clinical Pharmacology & Toxicology|October 11, 2011
A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned miceJiri Kassa, Kamil Musilek, Marketa Koomlova, et al.
Neurotoxicity Research|April 24, 2007
In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 4, 2020
Taking advantage of cellular uptake of ferritin nanocages for targeted drug deliveryBarbora Tesarova, Kamil Musilek, Simona Rex, et al.
Pageof 20